14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Tuesday, 7th May 2024 ACAD stock ended at $17.25. This is 1.47% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 3.31% from a day low at $16.76 to a day high of $17.31.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Apr 02, 2024 $18.04 $18.25 $17.86 $18.11 1 227 152
Apr 01, 2024 $18.59 $18.59 $17.91 $18.26 1 131 227
Mar 28, 2024 $18.20 $18.50 $18.05 $18.49 1 481 512
Mar 27, 2024 $17.90 $18.20 $17.73 $18.20 1 622 201
Mar 26, 2024 $17.95 $18.02 $17.68 $17.79 1 367 254
Mar 25, 2024 $18.00 $18.18 $17.56 $17.84 1 781 975
Mar 22, 2024 $18.34 $18.39 $17.91 $17.95 1 480 398
Mar 21, 2024 $18.67 $19.00 $18.31 $18.41 1 929 481
Mar 20, 2024 $18.60 $18.78 $18.30 $18.66 1 403 534
Mar 19, 2024 $18.63 $18.91 $18.47 $18.70 1 845 378
Mar 18, 2024 $18.59 $18.77 $18.16 $18.72 1 860 112
Mar 15, 2024 $18.62 $18.83 $18.21 $18.48 3 560 924
Mar 14, 2024 $19.48 $19.48 $18.55 $18.73 2 697 567
Mar 13, 2024 $19.91 $20.34 $19.16 $19.56 2 637 720
Mar 12, 2024 $19.49 $20.48 $19.11 $19.98 7 377 528
Mar 11, 2024 $23.30 $24.27 $23.26 $24.13 1 463 982
Mar 08, 2024 $23.93 $24.14 $23.22 $23.44 2 000 984
Mar 07, 2024 $23.42 $24.13 $23.32 $23.52 1 207 974
Mar 06, 2024 $24.02 $24.16 $22.98 $23.20 2 177 500
Mar 05, 2024 $23.81 $24.20 $23.69 $23.81 1 260 581
Mar 04, 2024 $24.01 $24.22 $23.50 $23.75 1 307 406
Mar 01, 2024 $23.50 $24.53 $23.35 $24.01 2 401 182
Feb 29, 2024 $24.30 $24.30 $22.98 $23.24 2 590 513
Feb 28, 2024 $24.64 $25.17 $23.36 $23.75 4 828 621
Feb 27, 2024 $26.04 $26.56 $25.60 $26.36 1 938 210
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT